XML 29 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Change in accounting principle
6 Months Ended
Jun. 30, 2022
Change in accounting principle [Abstract]  
Change in accounting principle
9.  Change in accounting principle

Effective April 1, 2022, TransAct changed its method of inventory valuation from standard costing which approximates FIFO to the average costing methodology.  We believe this methodology is preferable because it reflects a better measurement estimate of inventory cost as we do not typically perform intensive manufacturing of our finished products which are therefore better measured under average cost.  In addition, our business is projected to include an increasing sales volume of software going forward, which better aligns with average costing.  Comparative financial statements of prior periods have been adjusted to apply the new method retrospectively.  Tax effects are calculated at the Company’s marginal tax rate, or the tax impact of incremental income changes rather than the average tax rate applied to our total net loss before income taxes.  The following financial statement line items for the periods presented were impacted by the change in accounting principle.

The effect of the changes made to the Company’s Condensed Consolidated Balance Sheets follows:

   
December 31, 2021
 
 
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
 
Inventories
 
$
7,720
   
$
7,711
   
$
(9
)
Deferred tax assets
   
5,141
     
5,143
     
2
 
Retained earnings
   
15,573
     
15,566
     
(7
)

The ending balance in retained earnings as of December 31, 2020 was adjusted from $19,718 to $19,607.

The effect of the changes made to the Company’s Condensed Consolidated Statements of Operations follows:

   
Three months ended March 31, 2022
   
Three months ended June 30, 2021
 
 
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
   
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
 
Cost of sales
 
$
6,708
   
$
7,136
   
$
428
   
$
6,000
   
$
5,893
   
$
(107
)
Gross profit
   
2,994
     
2,566
     
(428
)
   
3,325
     
3,432
     
107
 
Operating loss
   
(5,176
)
   
(5,604
)
   
(428
)
   
(2,755
)
   
(2,648
)
   
107
 
Loss before income taxes
   
(5,275
)
   
(5,703
)
   
(428
)
   
(2,801
)
   
(2,694
)
   
107
 
Income tax benefit
   
1,262
     
1,355
     
93
     
687
     
664
     
(23
)
Net loss
   
(4,013
)
   
(4,348
)
   
(335
)
   
(2,114
)
   
(2,030
)
   
84
 
                                                 
Net loss per common share:
                                               
Basic
 
$
(0.41
)
 
$
(0.44
)
 
$
(0.03
)
 
$
(0.24
)
 
$
(0.23
)
 
$
0.01
 
Diluted
 
$
(0.41
)
 
$
(0.44
)
 
$
(0.03
)
 
$
(0.24
)
 
$
(0.23
)
 
$
0.01
 
                                                 
Shares used in per-share calculation:
                                               
Basic
   
9,886
     
9,886
             
8,976
     
8,976
         
Diluted
   
9,886
     
9,886
             
8,976
     
8,976
         

   
Six months ended June 30, 2021
 
 
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
 
Cost of sales
 
$
11,112
   
$
10,855
   
$
(257
)
Gross profit
   
6,514
     
6,771
     
257
 
Operating loss
   
(5,421
)
   
(5,164
)
   
257
 
Loss before income taxes
   
(5,563
)
   
(5,306
)
   
257
 
Income tax benefit
   
1,243
     
1,187
     
(56
)
Net loss
   
(4,320
)
   
(4,119
)
   
201
 
                         
Net loss per common share:
                       
Basic
 
$
(0.48
)
 
$
(0.46
)
 
$
0.02
 
Diluted
 
$
(0.48
)
 
$
(0.46
)
 
$
0.02
 
                         
Shares used in per-share calculation:
                       
Basic
   
8,962
     
8,962
         
Diluted
   
8,962
     
8,962
         

The effect of the changes made to the Company’s Condensed Consolidated Statements of Comprehensive Loss follows:

   
Three months ended March 31, 2022
   
Three months ended June 30, 2021
 
 
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
   
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
 
Net loss
 
$
(4,013
)
 
$
(4,348
)
 
$
(335
)
 
$
(2,114
)
 
$
(2,030
)
 
$
84
 
Comprehensive loss
   
(4,055
)
   
(4,390
)
   
(335
)
   
(2,082
)
   
(1,998
)
   
84
 

   
Six months ended June 30, 2021
 
 
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
 
Net loss
 
$
(4,320
)
 
$
(4,119
)
 
$
201
 
Comprehensive loss
   
(4,235
)
   
(4,034
)
   
201
 

The effect of the changes made to the Company’s Condensed Consolidated Statements of Cash Flows follows:

   
Three months ended March 31, 2022
   
Six months ended June 30, 2021
 
 
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
   
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
 
Net loss
 
$
(4,013
)
 
$
(4,348
)
 
$
(335
)
 
$
(4,320
)
 
$
(4,119
)
 
$
201
 
Deferred income taxes
   
(1,262
)
   
(1,355
)
   
(93
)
   
(1,209
)
   
(1,153
)
   
56
 
Inventories
   
(1,344
)
   
(916
)
   
428
     
2,591
     
2,334
     
(257
)

The effect of the changes made to the Company’s Condensed Consolidated Statements of Changes in Shareholders’ Equity follows:

   
Three months ended March 31, 2022
   
Three months ended June 30, 2021
 
 
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
   
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
 
Equity beginning balance
 
$
38,991
   
$
38,984
   
$
(7
)
 
$
28,363
   
$
28,369
   
$
6
 
Retained earnings -- beginning of period
   
15,573
     
15,566
     
(7
)
   
17,512
     
17,518
     
6
 
Net loss
   
(4,013
)
   
(4,348
)
   
(335
)
   
(2,114
)
   
(2,030
)
   
84
 
Retained earnings -- end of period
   
11,560
     
11,218
     
(342
)
   
15,398
     
15,488
     
90
 
Equity ending balance
   
35,113
     
34,771
     
(342
)
   
26,873
     
26,963
     
90
 

   
Six months ended June 30, 2021
 
 
Under
FIFO Cost
   
Under
Average Cost
   
Effect
of Change
 
Equity beginning balance
 
$
30,236
   
$
30,125
   
$
(111
)
Retained earnings -- beginning of period
   
19,718
     
19,607
     
(111
)
Net loss
   
(4,320
)
   
(4,119
)
   
201
 
Retained earnings -- end of period
   
15,398
     
15,488
     
90
 
Equity ending balance
   
26,873
     
26,963
     
90